9 employees
Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.
2019
$8.2M
from 3 investors over 3 rounds
Qlaris Bio, Inc. raised $8.2M on August 28, 2019
Investors: Correlation Ventures, Mayo Clinic Ventures and New Leaf Venture Partners